Please log in to view this page
Username
Password
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
